The acquisition of Riverpoint Medical strengthens Novanta’s position in high-growth medical markets and expands our capabilities in minimally invasive surgery.
Today marks an important milestone for our company as we officially welcome Riverpoint Medical to Novanta following the completion of our acquisition. This exciting step strengthens our position in attractive, high-growth medical markets and expands our capabilities in minimally invasive surgy.
Riverpoint brings industry-leading expertise in minimally invasive surgical products, advanced materials and coatings, and strong relationships with many of the world’s leading medical device companies. Just as importantly, Riverpoint brings a talented team with a strong reputation for innovation, quality and customer focus.
Together, we have an opportunity to build on the strengths of both organizations while continuing to serve customers and execute our growth strategy. Our goal is not simply to integrate two organizations. Our goal is to create a stronger company for customers, employees and shareholders by combining the strengths, capabilities and experience of both teams.
This acquisition is an important step in strengthening our portfolio and advancing our long-term growth strategy. Most importantly, it brings a talented team of employees to Novanta, and we are excited to build our future together.